Recent TCBP News
- /C O R R E C T I O N -- TC BioPharm/ • PR Newswire (US) • 01/07/2025 02:26:00 AM
- TCBP Trading Continues Unabated on Nasdaq Stock Exchange • PR Newswire (US) • 01/06/2025 06:30:00 PM
- TCBP Provides Update on Acquisition Strategy and Current Targets • PR Newswire (US) • 12/31/2024 03:15:00 PM
- TCBP Issues 25% Stock Dividend • PR Newswire (US) • 12/30/2024 03:30:00 PM
- TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients • PR Newswire (US) • 12/20/2024 01:30:00 PM
- TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend • PR Newswire (US) • 12/18/2024 01:30:00 PM
- TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy • PR Newswire (US) • 12/11/2024 12:00:00 PM
- TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial • PR Newswire (US) • 12/04/2024 01:30:00 PM
- TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant • PR Newswire (US) • 11/12/2024 02:30:00 PM
- TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements • PR Newswire (US) • 10/30/2024 12:30:00 PM
- TCBP Responds to False Social Media Claim • PR Newswire (US) • 10/25/2024 01:45:00 PM
- Biotech Shares Rip Following Collaboration Announcement For Monkeypox Research • AllPennyStocks.com • 10/22/2024 05:45:00 PM
- TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic • PR Newswire (US) • 10/22/2024 12:30:00 PM
- TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening • PR Newswire (US) • 10/03/2024 12:30:00 PM
- TCBP Announces Site Opening of Guys and St. Thomas Hospital • PR Newswire (US) • 09/25/2024 12:30:00 PM
- TCBP to Present at the 2024 ThinkEquity Conference in NYC • PR Newswire (US) • 09/24/2024 12:45:00 PM
- /C O R R E C T I O N -- TC BioPharm/ • PR Newswire (US) • 09/20/2024 08:00:00 PM
- TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial • PR Newswire (US) • 09/12/2024 12:30:00 PM
- TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox • PR Newswire (US) • 09/09/2024 12:30:00 PM
- TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox • PR Newswire (US) • 09/06/2024 08:00:00 PM
- TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 09/05/2024 12:30:00 PM
- TCBP Announces Dosing of 5 New Patients in ACHIEVE • PR Newswire (US) • 09/03/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/30/2024 07:52:09 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/29/2024 09:11:40 PM
- Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)] • Edgar (US Regulatory) • 08/28/2024 10:32:48 PM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • BLO • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM
Fifty 1 Labs, Inc. Launches Dedicated Website for Shareholders and Investors, Company now current with OTC Markets • CAFI • Jan 7, 2025 9:00 AM
EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion • EZFL • Jan 7, 2025 8:35 AM
CGRA Signs Binding Term Sheet to Merge With American Infrastructure Corporation, a Subsidiary of Nasdaq-listed American Resources Corporation (Nasdaq: AREC) • CGRA • Jan 6, 2025 10:31 AM